TOTAL DONATIONS MAY €60. Renaissance cannot run on €60 and a British pension. Renaissance could fold unless it is better supported. Please help to keep us going – Donations are easily made (EU, US, UK) For details contact Michael Walsh firstname.lastname@example.org
Leading medical journal, The BMJ has published an incendiary report exposing faked data, blind trial failures, poorly trained vaccinators, and a slow follow-up on adverse reactions in the phase-three trial of Pfizer’s Covid jab.
Central to the exposé is Brook Jackson, who, for two weeks, served as regional director at Ventavia Research Group, the company contracted to assist with the pivotal trial. She provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails supporting her concerns.
Jackson reveals that Ventavia staff who conducted quality-control checks were overwhelmed by the volume of problems they were identifying. She repeatedly informed her superiors of poor laboratory management, and patient safety and data integrity issues.
In a cited internal document from August 2020, shortly after the Pfizer trial began, a Ventavia executive identified three site staff members delegated to ‘go over e-diary issue/falsifying data, etc.’ One employee was said to have been subsequently ‘verbally counselled for changing data’ and ‘not noting late entry.’
Jackson reported her concerns to the US Food and Drug Administration (FDA), but was fired later the same day on the basis that she was ‘not a good fit.’
In a recording of a late September meeting provided by Jackson, in which she met with two Ventavia directors, the unwelcome prospect of an FDA inspection had been openly discussed. ‘We’re going to get some kind of letter of information at least, when the FDA gets here, I know it,’ one said to Jackson.
Another former Ventavia employee has confirmed that the company had been expecting a federal audit of its Pfizer vaccine trial, though this did not materialise. A 2007 US Department of Health report found that, between 2000 and 2005, the FDA inspected just 1% of clinical trial sites, while, in 2020, just 50 on-site visits were conducted.
In the aforementioned recording, an executive can also be heard explaining that, when examining paperwork for trial quality control, the company wasn’t able to quantify the types and number of errors that were being identified. ’In my mind, it’s something new every day,’ the senior staffer says. ’We know that it’s significant.’
In September, an email sent to Ventavia by Icon, the research organization Pfizer partnered on the trial, shows Icon was dissatisfied with Ventavia’s inability to keep up with data entry queries.
Among those queries were two cases in which test subjects had ’reported with severe symptoms/reactions.’ According to protocol, subjects experiencing grade-three local reactions, severe redness, swelling, or pain at the injection site, should have been contacted.
Icon asked for confirmation as to whether contact had indeed been made, so as to ascertain further details and determine whether a site visit is clinically indicated and that the subjects’ forms be updated accordingly.
The day after her meeting with her directors, Jackson submitted a complaint to the FDA. She listed a dozen issues she’d personally witnessed, including participants being placed in a hallway after injection and not being monitored by clinical staff, a lack of timely follow-up of patients who experienced adverse events, protocol deviations not being reported, vaccines not being stored at proper temperatures, mislabelled laboratory specimens, and the targeting by Ventavia of staff who reported these problems.
Jackson’s account has been reinforced by several former Ventavia employees who have either since departed or been fired from the company. An executive present at the September meeting has since apologised to her, assuring her that everything she had complained about was spot-on.
Two of those employees spoke anonymously to The BMJ, confirming broad aspects of Jackson’s complaint. One, who has worked on more than four dozen clinical trials during her career, said she had never experienced such a helter-skelter work environment as that she encountered during Ventavia’s Pfizer trial. She also confirmed that the problems pinpointed by Jackson had persisted at the company after her dismissal. For instance, in several cases, there hadn’t been enough employees to swab for infection all trial participants who reported Covid-like symptoms.
‘I’ve never had to do what they were asking me to do, ever. It just seemed like something a little different from normal, the things that were allowed and expected,’ the employee told The BMJ. ’I don’t think it was good clean data [that the trial generated]. It’s a crazy mess.’
The second former employee echoed the first’s comments, describing the environment at Ventavia as unlike any they’d experienced in their 20-year research career. Shortly after Jackson was fired, they also alleged that Pfizer was notified of problems with the vaccine trial at Ventavia and that an audit took place.
Yet, in the briefing document, Pfizer submitted to the FDA advisory committee in December 2020 in support of its application for emergency-use vaccine authorization, no mention was made of any problems at Ventavia. The next day, authorization was duly granted.
In August this year, after full approval was granted for Pfizer’s jab, the FDA published a summary of its inspections of the company’s vaccine trial sites. Nine of the 153 had been inspected, but none of those had been operated by Ventavia, and no inspections had been conducted at all in the eight months after the December 2020 emergency authorisation, on the basis that ’the study was ongoing, and the data required for verification and comparison were not yet available.’
Pfizer has since hired Ventavia as a research subcontractor to work on four other clinical trials: the use of the Covid-19 vaccine in children and young adults; a Covid-19 trial involving pregnant women; a trial of Covid-19 booster doses; and a trial of a jab for the respiratory syncytial virus.
RT contacted Pfizer’s press office for comment, but the email bounced back, returning the automated message ’The recipient’s mailbox is full and can’t accept messages now.’
By Kit Klarenberg, an investigative journalist exploring the role of intelligence services in shaping politics and perceptions. Follow him on Twitter @KitKlarenberg
Think your friends would be interested? Share this story!
Donate: It is the generosity of our supporters and members that makes our vital work possible. As the storm clouds of crisis and the pain of injustice and persecution loom over our people, the potential and importance of our work grows day-by-day. There is no George Soros figure out there for nationalists, so we can only do what good people like you help us to do. Thank you for your faith and your generous commitment: contact Michael Walsh email@example.com
Think your friends would be interested? Share or reblog this story!
MICHAEL WALSH is a journalist, broadcaster and the author of RISE OF THE SUN WHEEL, EUROPE ARISE, TROTSKY’S WHITE NEGROES, MEGACAUST, DEATH OF A CITY, WITNESS TO HISTORY, THE BUSINESS BOOSTER , THE FIFTH COLUMN VOLUME I and II, FOR THOSE WHO CANNOT SPEAK, IMMORTAL BELOVED, THE ALL LIES INVASION, INSPIRE A NATION Volume I, INSPIRE A NATION Volume II , SLAUGHTER OF A DYNASTY , REICH AND WRONG, THE RED BRIGANDS, RANSACKING THE REICH , SCULPTURES OF THE THIRD RIECH: ARNO BREKER AND REICH SCULPTORS , SCULPTURES OF THE THIRD RIECH: JOSEF THORAK AND REICH SCULPTORS , SCULPTURES OF THE THIRD REICH VOLUME III Porcelain and Reich Sculptors, The Exiled Duke Romanov Who Turned Desert Into Paradise , THE DOVETAILS , SEX FEST AT TIFFANY’S, THE AMOROUS GHOST AND ENCOUNTERS and other book titles. These illustrated best-selling books are essential for the libraries of informed readers.
MICHAEL WALSH NOVELS
The revenge of a predator is a city-vigilante epic better than Death Wish A LEOPARD IN LIVERPOOL , 55 lavishly illustrated first-hand stories by a Liverpool sailor THE LEAVING OF LIVERPOOL, Latest Killer-Thriller From Michael Walsh the City Vigilante Supremo The Stigma Enigma , A powerful thought-provoking paranormal romance The Soul Meets, How to form a naughty ménage a trois THE DOVETAILS and SEX FEST AT TIFFANY’S.
THE AMOROUS GHOST AND ENCOUNTERS Michael Walsh. A novel but not a work of fiction. Drawing on his real-life and location experiences this romantic-supernatural biography will ravish the reader. A page-turning terrifying white knuckle ride because these are his real-life apparitional experiences. AMAZON/KINDLE
Latest Michael Walsh bestsellers: Those who fall victim to the taxman, banks and moneylenders are victims of legalised mugging DEBTOR’S REVENGE, The Business Booster shows you how to double your profits not your workload THE BUSINESS BOOSTER
MICHAEL WALSH is a journalist, author, and broadcaster. His 70 books include best-selling RHODESIA’S DEATH EUROPE’S FUNERAL, AFRICA’S KILLING FIELDS, THE LAST GLADIATORS, A Leopard in Liverpool, RISE OF THE SUN WHEEL, EUROPE ARISE, FOR THOSE WHO CANNOT SPEAK, THE ALL LIES INVASION, INSPIRE A NATION Volume I, INSPIRE A NATION Volume II, and many other book titles. These illustrated best-selling books are essential for the libraries of informed readers.
We are in debt to our donors who finance the distribution of spin-free real news and fearlessly expressed views.
BUY FROM AUTHOR
MEGACAUST Michael Walsh. R. J. Rummel, Power Kills: Genocide and Mass Murder (Journal of Peace Research) 164 million people have been killed in cold blood this century by Capitalist / Communist governments.
SLAUGHTER OF A DYNASTY Michael Walsh. Covertly sponsored by Wall Street banks and the White House Bolsheviks seized Tsarist Russia (regime change). For 36 years news of Bolshevik atrocities and 70 million martyred Christians were censored by Western media. Lavishly illustrated, this expose reveals secrets removed from Western history books.
When ordering the book contact Michael Walsh by email firstname.lastname@example.org to receive your signed copy.
KEEP REAL NEWS OPEN: Donate by using Western Union, MoneyGram, Ria, registered mail or contact Michael Walsh: email@example.com or firstname.lastname@example.org 2) Follow our blog. 3) Share our stories and 4) buy our author-signed books. 5) Receive free newsletters by writing subscribe to email@example.com
BOOKS THAT CHALLENGE, INSPIRE, INFORM Michael Walsh, ‘Writer of the Year’ with a strong global following. Nearly 70 interesting Amazon book titles famed for changing and improving lives. CLICK TO VIEW
New stories every day!
Categories: Current Events